Feasibility test of a personality-targeted psychosocial intervention for polysubstance use in individuals receiving opioid substitution therapy (OST)pain syndromes, with polysubstance misuse and treatment retention in OST
Secondary analyses of the pathways between impulsivity, emotion regulation deficits, and comorbid. The ongoing opioid use crisis in Canada has been worsened by societal disruptions caused by the COVID-19 pandemic. Effective treatments for opioid use disorders (OUDs) are desperately needed. Opioid substitution treatment (OST), using medications like methadone or buprenorphine, is the most effective treatment for OUD. However, OST patients continue to experience significant problems, including high levels of treatment dropout, and ongoing polysubstance use, including use of sedatives like benzodiazepines and alcohol which increase the risk of overdose death. This feasibility study will investigate a psychosocial treatment, OpiVenture, that targets four personality traits associated with drug use, and measure its effects on polysubstance use and treatment retention in OST patients. This information, along with input from OST patients and treatment providers, will be used to determine whether OpiVenture should be incorporated into treatment of OUD in Canada, to improve the health and quality of life of Canadians affected by opioid addiction.